⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1291214 | 0.97 | — | — | |
| SCHEMBL27603690 | 0.81 | — | — | |
| SCHEMBL197323 | 0.73 | — | — | |
| SCHEMBL467469 | 0.73 | — | — | |
| SCHEMBL3905502 | 0.73 | — | — | |
| SCHEMBL10904067 | 0.73 | — | — | |
| SCHEMBL3613683 | 0.73 | — | — | |
| SCHEMBL6593341 | 0.73 | — | — | |
| SCHEMBL3661091 | 0.73 | — | — | |
| SCHEMBL9139976 | 0.71 | LCK (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1315507-A4 | HPV-SPECIFIC SHORT-MERS | MICROLOGIX BIOTECH INC (CA) | 2004-06-16 | — | — | EP | disclosed |
| EP-1315507-A2 | HPV-SPECIFIC SHORT-MERS | Origenix Technologies, Inc. (CA) | 2003-06-04 | — | — | EP | disclosed |
| EP-0833902-B1 | OLIGONUCLEOTIDES SPECIFIC FOR HEPATITIS C VIRUS | HYBRIDON INC (US) | 2003-05-14 | — | — | EP | disclosed |
| US-20030055240-A1 | HPV specific oligonucleotides | IDERA PHARMACEUTICALS, INC | 2003-03-20 | — | — | US | disclosed |
| US-6509149-B2 | Nuclelotide sequences for use in the diagnosis and treatment of human papilloma virus | HYBRIDON, INC. | 2003-01-21 | — | — | US | disclosed |
| US-6458940-B2 | HPV-specific oligonucleotides | HYBRIDON, INC. | 2002-10-01 | — | — | US | disclosed |
| US-20020081577-A1 | OLIGONUCLEOTIDES SPECIIFIC FOR HEPATITIS C VIRUS | IDERA PHARMACEUTICALS, INC. | 2002-06-27 | — | — | US | disclosed |
| US-20020068820-A1 | HPV-SPECIFIC OLIGONUCLEOTIDES | IDERA PHARMACEUTICALS, INC | 2002-06-06 | — | — | US | disclosed |
| WO-2001077294-A2 | HPV-SPECIFIC SHORT-MERS | ORIGENIX TECHNOLOGIES, INC. (CA) | 2001-10-18 | — | — | WO | disclosed |
| US-20010010899-A1 | HPV-SPECIFIC OLIGONUCLEOTIDES | IDERA PHARMACEUTICALS, INC | 2001-08-02 | — | — | US | disclosed |
| EP-0832214-B1 | OLIGONUCLEOTIDES SPECIFIC FOR HUMAN PAPILLOMAVIRUS | HYBRIDON INC (US) | 2000-12-27 | — | — | EP | disclosed |
| EP-0833902-A2 | OLIGONUCLEOTIDES SPECIFIC FOR HEPATITIS C VIRUS | HYBRIDON, Inc. (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0832214-A2 | OLIGONUCLEOTIDES SPECIFIC FOR HUMAN PAPILLOMAVIRUS | HYBRIDON, Inc. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996039500-A2 | OLIGONUCLEOTIDES SPECIFIC FOR HEPATITIS C VIRUS | HYBRIDON INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996039501-A2 | OLIGONUCLEOTIDES SPECIFIC FOR HUMAN PAPILLOMAVIRUS | HYBRIDON INC. (US) | 1996-12-12 | — | — | WO | disclosed |